This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Assistance Publique Hopitaux De Marseille, National Institute of Health and Medical Research, Université´ D'aix-Marseille. Active years: 2017-2019.
Company Filing History:
1 out of 18 
1 out of 1,853 
1 out of 236 
Years Active: 2017-2019
Title: Caroline Rozan: Innovator in Antigen Binding Formats
Introduction
Caroline Rozan is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of therapeutic treatments and diagnostic assays through her innovative work. With a total of 2 patents, her inventions focus on advanced antigen binding formats.
Latest Patents
Caroline Rozan's latest patents include groundbreaking work on antigen binding formats for use in therapeutic treatments or diagnostic assays. The invention details a unique antigen-binding format that consists of a first fusion protein, where the CH1 constant domain of an antibody is fused by its N-terminal end to the C-terminal end of a variable domain of an antibody, and by its C-terminal end to the N-terminal end of another variable domain of an antibody. Additionally, a second fusion protein is described, wherein the CL constant domain of an antibody is fused by its N-terminal end to the C-terminal end of a variable domain of an antibody.
Career Highlights
Throughout her career, Caroline has worked with esteemed organizations, including the Institut National de la Santé et de la Recherche Médicale. Her work has been instrumental in advancing the understanding and application of antigen binding formats in medical science.
Collaborations
Caroline has collaborated with notable professionals in her field, including Daniel Baty and Patrick Chames. These collaborations have further enriched her research and innovation efforts.
Conclusion
Caroline Rozan stands out as a key figure in the development of antigen binding formats, contributing valuable inventions that enhance therapeutic and diagnostic capabilities. Her work continues to influence the medical research landscape.